M. de Miguel

机构：HM Hospitales, Hospital Universitario HM Sanchinarro

发表论文 3 篇 · 总被引 1 次 · h-index 1

代表论文

• Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met–Targeting Antibody–Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer (2026 · Clinical Cancer Research · 被引 1)
• The pivotal PYNNACLE phase 2 trial assessing rezatapopt, a selective p53 reactivator, in patients with advanced or metastatic solid tumors harboring a TP53 Y220C mutation: Interim analysis of patients with ovarian cancer (2026 · Gynecologic Oncology)
• Abstract PS1-08-24: A phase 1/2 trial of LY4064809 (STX-478), a pan-mutant-selective PI3Kα inhibitor in HR+, HER2- advanced breast cancer (ABC): Updated results from PIKALO-1 (2026 · Clinical Cancer Research)